1. Estimating the value of pneumococcal conjugate vaccines for improving the health of HIV exposed children in PEPFAR focus countries.
Chuka Anude, Maria Knoll, Katherine L. O’Brien, Orin S. Levine
2. Modeling the potential impact of pneumococcal conjugate vaccine on mortality in a rural district in Kenya.
Moïsi JC, Gatakaa H, Jefwa MK, Nyundo C, Ndiritu M, Levine OS and Scott JAG
3. Dynamics of transplacental transfer of maternal dengue antibodies among mothers and infants in Bangkok.
Willem G. van Panhuis and Anna P. Durbin
4. Comparison of “antibody in lymphocyte supernatant” (ALS) and ELISPOT assays for indirect detection of mucosal immune responses to Shigella LPS in clinical specimens
Andrea M. Jones, Robin McKenzie, David N. Taylor, Colleen M. Carpenter Shannon L. Grahek, Malabi M. Venkatesan, Thomas L. Hale, August L. Bourgeois
5. SOCS-1 silencing in measles virus primed dendritic cells enhances presentation of measles virus and other (influenza virus) antigens.
Zaza Ndhlovu and Diane E Griffin
6. Effects of exogenous estrogen & progesterone on the natural history of the human papillomavirus: Implications for vaccine induced immunogenicity & long-term efficacy
Marks M., Gravitt P. , Celentano D. , Klein,S.
7. Streptococcus Pneumoniae meningitis surveillance in children under five years of age in Santo Domingo, Dominican Republic
Feris J, Coradin H, Gilani Z, Sanchez J, Floren A, Peynado M, del Moral T, Pena C, Fernandex J, Deloria-Knoll, M, Perez-Then E
8. Hib and SP Meningitis CFR by WHO Region and Mortality Strata.
Gilani Z, Deloria-Knoll M, O'Brien KL, Wolfson LJ, Watt JP, Henkle E, McCall N, Lee E, Mulholland K, Levine O, Cherian T for the Hib and Pneumococcal Global Disease Burden Study Team
9. Age Distribution of Sp and Hib Meningitis Cases: The Hib and SP Global Disease Burden Project.
Henkle E, Cherian T, Knoll M, Levine OS, Mulholland K, Watt JP, Wolfson L and O’Brien KL, for the Hib and SP GDB Study Team
10. Understanding poor CD8+ T cell responses to peptide-based vaccination
Michael G. Overstreet, Helen Freyberger, Fidel Zavala
11. Country and Regional Representation of Meningitis Incidence Data for Hib and Spn Global Disease Burden Estimates.
Knoll MD, Henkle EM, Grant LR, Wolfson LJ, Watt JP, O’Brien KL, Mulholland K, Levine OS, Cherian T, for the Hib and Spn Global Disease Burden Study Team
12. Costs and cost-effectiveness of immunisation programmes: the role of lay health workers.
Adrijana Corluka, Damian G. Walker, Simon Lewin, Inger Scheel, Claire Glenton, Marit Johansson
13. The art of modeling vaccine decision making: an interdisciplinary approach.
Meghan Stack and Marcie Richmond
14. Influenza vaccine effectiveness during the 2006-7 season in HIV-infected and -uninfected women: Nested studies in the Women’s Interagency HIV Study (WIHS)
Keri N. Althoff, Maryna Eichelberger, Jin Gao, Stephen J. Gange
15. The 1918 Influenza Pandemic Experience in Japan: Age and Geographic Mortality Patterns
S. A. Richard, N. Sugaya, L. Simonsen, M. A. Miller, C. Viboud
16. Acceptability Survey of HPV Vaccine Among Female Sex Workers in Lima, Peru.
Brandon Brown, Neal Halsey, Cesar Carcamo, Maria Valderrama, and Magaly Blas
17. Markedly Enhanced Immunogenicity of a Pfs25 DNA-Based Malaria Transmission-Blocking Vaccine by In Vivo Electroporation.
Ralph LeBlanc, Yessika Vasquez, Drew Hannaman and Nirbhay Kumar
18. Sex Differences in Response to Influenza: Implications for Vaccination
Dionne P. Robinson, Jenifer B. Kaplan, and Sabra L. Klein
19. Whole genome sequence analysis of human AU-1-like rotavirus isolates with mixed genotypes from a Brazilian outbreak.
Kaitlin R. Lovett, Takeshi Tsugawa, and Yasutaka Hoshino
20. The value of vaccination: Examining the long-term economic consequences of vaccines
Julia Driessen, Abdur Razzaque, Damian Walker, David Canning
|
